DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Yao JC. et al.
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.
J Clin Oncol 2017;
35: 1695-1703
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.